Allergy & Immunology
Pollinex Quattro grass dosing begins in first-ever global allergy vaccine trial
Published in Hospital Business Week, February 25th, 2007
This international trial will be undertaken at approximately 96 centres in 4 countries and will involve enrolment of over 1000 patients. The majority of patients will be recruited in the United States.
Pollinex Quattro is an ultra-short course vaccine requiring only four shots over three weeks and incorporates the TLR4 agonist adjuvant MPL. In contrast, existing vaccine treatments typically require between 16 and 50 injections taken under specialist...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Ascites
Researchers at Hamad Medical Corporation, Department of Medicine have published new data on ascites - Birth Defects
Birth defect hospitalizations cost $2.6 billion annually - Brain Cancer Epidemiology
Research on brain cancer epidemiology detailed by scientists at Eli Lilly and Company - Business & Finance
Akers Bioscience reports 2006 revenues expected to be $5.2 million in fourth growth year - Business Update
Accenture prototype shows benefits of nationwide health information network - Business Update
Agreement between Avalon, MDVIP allows consumers to add physician service toward deductibles - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
